All In Biotech

Drug Trial Radar · NCT03927144

Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients

A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Active-controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (AMG334 qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients

Last checked: Nov 20, 2026Latest source record: Nov 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 621 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

621

Actual

Start

May 15, 2019

Primary completion

Oct 1, 2021

Study completion Sep 30, 2022

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
Collaborators
Novartis
First posted
Apr 25, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the sustained long-term benefit between two treatment paradigms of migraine prophylactic agents (erenumab versus a control arm of oral prophylactics) in episodic migraine patients who have previously failed 1 to 2 prophylactic migraine treatments.

Conditions

  • Episodic Migraine

Interventions

  • AMG334Drug

    Subcutaneous Injection

  • Oral ProphylacticDrug

    SOC Oral Tablet/Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Who Completed Initially Assigned Treatment and Achieved at Least a 50% Reduction From Baseline in Monthly Migraine Days at Month 12Time frame: Baseline and Month 12

Locations

112 sites in 18 countries. Site status is shown where the registry gives one.

  • Stanford Headache Center

    Stanford, California

  • Yale Center for Clinical Research

    New Haven, Connecticut

  • New England Institute for Neurology and Headache

    Stamford, Connecticut

  • George Washington Hospital

    Washington D.C., District of Columbia

  • University of Miami Headache Division

    Miami, Florida

  • Premier Research Institute

    West Palm Beach, Florida

  • Diamond Headache Clinic

    Chicago, Illinois

  • Robbins Headache Clinic

    Riverwoods, Illinois

  • Medvadis

    Watertown, Massachusetts

  • New England Regional Headache Center, Inc

    Worcester, Massachusetts

  • MHNI

    Ann Arbor, Michigan

  • Clinical Research Institute

    Minneapolis, Minnesota

  • The Headache Center

    Ridgeland, Mississippi

  • Study Metrix Research

    City of Saint Peters, Missouri

  • Mercy Health Research

    St Louis, Missouri

  • Laszlo Mechtler

    Amherst, New York

  • Jefferson Headache Center

    Philadelphia, Pennsylvania

  • Nashville Neuroscience Group

    Nashville, Tennessee

  • Texas Neurology

    Dallas, Texas

  • Texas Institute for Neurological Disorders

    Sherman, Texas

  • IDIM Instituto de Investigaciones Metabolicas

    Buenos Aires, Argentina

  • Mautalen Salud e Investigacion

    Ciudad Autonoma de Bs As, Argentina

  • Centro Medico Privado en Reumatologia

    San Miguel de Tucumán, Argentina

  • Univ. Klinik fuer Neurologie

    Innsbruck, Austria

  • Ordensklinikum Linz Barmherzigen Schwestern

    Linz, Austria

  • Univ Klinik fuer AKH

    Vienna, Austria

  • AZ Sint Jan

    Bruges, Belgium

  • UZ Brussel

    Brussels, Belgium

  • UZ Gent

    Ghent, Belgium

  • Jessa Ziekenhuis- Campus Virga Jesse Dienst Gastro-entrologie

    Hasselt, Belgium

  • Centre Hospitalier Regional de la Citadelle

    Liège, Belgium

  • Heilig Hart Ziekenhuis Lier

    Lier, Belgium

  • Neurologicka ambulance Quattromedica

    Brno, Czechia

  • NEUROHK sro

    Choceň, Czechia

  • Brain Soultherapy sro

    Kladno, Czechia

  • DADO Medical S R O

    Prague, Czechia

  • Thomayerova Nemocnice

    Prague, Czechia

  • Forbeli SRO

    Prague, Czechia

  • Institut neuropsychiatricke pece

    Prague, Czechia

  • Clintrial SRO

    Prague, Czechia

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.